NeuroSense Therapeutics (NRSN) Q2 2024 Earnings
NRSN·Reported September 30, 2024·Before market open
Diluted EPS came in at $-0.02, beat the $-0.20 consensus by $0.18.
Diluted EPS
$-0.02beat by $0.18
Consensus: $-0.20
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about NeuroSense Therapeutics's Q2 2024 earnings report.
NeuroSense Therapeutics (NRSN) reported Q2 2024 earnings on September 30, 2024 before market open.
NeuroSense Therapeutics reported diluted EPS of $-0.02 for Q2 2024.
EPS beat the consensus estimate of $-0.20 by $0.18.